chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My period cycle has been off since I received the 2nd vaccine. It has been early, late, lasted longer and shorter.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right (Lot number: EW0181) as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: Tomatoes, mangoes" (unspecified if ongoing), notes: known allergies: Tomatoes, mangoes.; "known allergies: Latex" (unspecified if ongoing), notes: known allergies: Latex; "known allergies: metals" (unspecified if ongoing), notes: known allergies: metals; "known allergies: fragrance" (unspecified if ongoing), notes: known allergies: fragrance; "known allergies: cleaning products" (unspecified if ongoing), notes: known allergies: cleaning products; "known allergies: rubber" (unspecified if ongoing), notes: known allergies: rubber. The patient took concomitant medications. Vaccination history included: Bnt162b2 (product: COVID 19, lot number: EW0186, lot unknown: False, administration date: 19Jun2021, administration time: 01:00 PM, dose number:1, vaccine location: Right arm.), administration date: 19Jun2021, when the patient was 36 years old, for COVID-19 immunization. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 19Jul2021, outcome "unknown", described as "My period cycle has been off since I received the 2nd vaccine. It has been early, late, lasted longer and shorter.". Therapeutic measures were not taken as a result of menstrual disorder.  Additional information: Patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Patient received list of Multi vitamin medications within two weeks of vaccination. She was not diagnosed with Covid-19 prior to vaccination. Since the vaccination, she has not been tested for Covid-19.  Follow-up attempts are completed. No further information is expected.
Information has been received from a RN concerning a pt who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The pt had a very red and painful arm for the entire day after the vaccine, that resolved in about a day as well. The pt was treated with ibuprofen (Advil) for pain relief and ice packs. It was noted the pt recovered. Unspecified medical attention was sought.  There was no product quality complaint involved. Followup information on 19Nov03 from the reporter indicated that two of the pt's may have had the vaccine a while ago and that she was not aware if any of the pts had any previous reactions to any other vaccines. The reporter expressed concern about the particular lot of the vaccine. It was noted that several pts developed severe local reactions from what appears to be the same lot and what appeared odd to the doctor was a man and his wife received pneumococcal. polysaccharide vaccine from two different lots and the male that had the different lot that the one mentioned had no adverse reaction but his wife complained of arm pain and tenderness. The records of testing prior to release of this lot have been check by QA and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  The reporter mentioned two other pts who developed a similar reaction after vaccination with pneumococcal 23v polysaccharide vaccine. No further information is expected.
some hours after the 2nd moderna vaccine had been administered, patient's left arm felt 'dead' for approximately one week - symptoms included: painful, red, swollen, hot to the touch from the injection site to the top half of her left forearm, and painful to move arm. symptoms lasted abt one week.  A week after that, the patient had what appeared to be a light case of shingles that was not particularly painful, eventually fading away in a few weeks with no medical attention. In  late October the shingles reappeared, this time a full blown case requiring medical attention. Her clinician prescribed steroids, an antifungal medication, and a topical cream. Patient still has shingles at this time, but the symptoms have slightly  improved
Information has been received from a physician concerning a female who was vaccinated with the second dose of Gardasil. Immediately afterward, the patient experienced numbness on one side of body. Additional information has been requested. It was reported that another female experienced numbness on one side of the body immediately after receiving Gardasil (WAES 0703USA02125)
Lymphadenopathy left subclavian discovered 24 hours after injection. Site tender to touch. Ibuprofen with warm compress used to treat.  Improvement in size after one week but still tender and palpable.
tested positive for covid virus; tested positive for covid virus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for covid virus". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  Clinical course: Caller mentioned that he just tested positive for covid virus and he was asking how long before he can get up his B4 booster shot after he had covid.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient described that she developed a red bump on middle of left arm after receiving the first Shingrix vaccine. Patient reported that she has never experienced this reaction to any previous vaccines. Patient reports bump healed on its own over time.
Patients arm started hurting evening of administration.  The next morning, patient was starting to have some pain extending down to elbow.  Upon examination, area where vaccination was administered was red, swollen, and starting to flare.  Patient was advised to take diphenhydramine and apply cold to area.  Injection site continued to flare, upon which patient proceded to see physician, where she was diagnosed with cellulitis and prescribed antibiotics for treatment.
Bell's Palsy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FACIAL PARALYSIS (Bell's Palsy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021 at 2:00 PM, the patient experienced FACIAL PARALYSIS (Bell's Palsy) (seriousness criterion medically significant). At the time of the report, FACIAL PARALYSIS (Bell's Palsy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment information was not reported.  Based on the current available information and temporal association between the use of the product and the onset date of the reported event of facial paralysis, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of facial paralysis, a causal relationship cannot be excluded.
reports fever, severe h/a, dizziness the day p/vax;stayed out of work in bed all that day;called clinic 25JUN & still having problem w/h/a & not feeling well although not as bad as on 20JUN;
10mins post vaccination pt reported dizziness. Vitals: 133/91, 69, 18 -- > 120/75, 66 Pt stable and released from the vaccination site
Chills; Nauseated; my incision or the shot site is red and swollen and very sore; my incision or the shot site is red and swollen and very sore; my incision or the shot site is red and swollen and very sore; headache; This is a spontaneous report from a contactable consumer medical social worker in the emergency department (patient).  A 24-year-old female patient received bnt162b2 (BNT162B2, Batch/lot # EK5730, Expiry Date Mar2021) intramuscularly at single dose in arm in Dec2020 about 12 hours ago before this report for Covid-19 immunisation, administered at the hospital that she work at.  Medical history was none. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) daily for birth control.  In Dec2020, about 10 hours after vaccination was received, the patient experienced chills, felt nauseated, her incision or the shot site is red and swollen and very sore and headache. No lab test performed. No treatment received. The outcome of headache was unknown of the other events was not recovered.
broke out in hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (broke out in hives) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-May-2021, the patient experienced URTICARIA (broke out in hives). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (broke out in hives) outcome was unknown.            Concomitant medications was not provided by the reporter.  Last week is the first week that patient has been able to go more than 3 days without the Zyrtec without a flare up.  Company Comment: This spontaneous case concerns a patient, of unknown age and gender, with no medical history reported, who experienced the unexpected, non-serious event of urticaria. The event occurred 9 days after administration of the second dose of the Moderna mRNA-1273 vaccine. The patient broke out in hives. The patient then took Zyrtec (cetirizine), unspecified dose and frequency, which afforded relief of symptoms. The event had resolved at the time of the report. The rechallenge was not applicable as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.; Sender's Comments: This spontaneous case concerns a patient, of unknown age and gender, with no medical history reported, who experienced the unexpected, non-serious event of urticaria. The event occurred 9 days after administration of the second dose of the Moderna mRNA-1273 vaccine. The patient broke out in hives. The patient then took Zyrtec (cetirizine), unspecified dose and frequency, which afforded relief of symptoms. The event had resolved at the time of the report. The rechallenge was not applicable as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report. Further information has been requested.
Given TD on 12/05/09 to patient. Came in 12/07/09 around 2:15 pm left arm was red, swollen. Was treated w/prescription. (cellulitis)
Myalgia, Arthralgia, 2/25/21 Still c/o intermittent pain mostly hands/shoulder/knees/ankles Narrative:  Other Relevant History:
Red blotchy rash on arms, chest, torso, and thighs. Did not itch. Saw doctor. He described as hypersensitivity rash. Prescription for prednisone. Short course of 5 days of medication.  Rash gone after day 4 and has not returned.
I had an sudden onset of imbalance.  The symptoms were difficulty walking straight, having to hold onto things so I didn't fall over, difficulty reading, and using a computer.   Also had ongoing nauseated several times per day requiring that I rest.  I still have symptoms but have had some improvement in late October, 2021.  There has been no treatment.
Severe vertigo, couldn't stand. Nausea, vomitting cold clammy skin, sweating, was given cat scan, treated with Antinausea & Antivertigo IV. Was diagnosis by ER as laby-Rinthitis, unknown origin suspected Flu vaccine reaction.
1 hour post vaccine sight pain 5 hours post vaccine severe sight pain, swollen armpit lymph nodes, painful skin 6 hours post vaccine, above plus painful muscles and joints 30 hours post vaccine above not resolved and severe chest pain when a normal breath is taken
Narrative: Patient reported throat swelling following administration of J&oJ covid vaccine requiring EPI-PEN injection which provided relief. Patient was transported to the ED via ambulance following administration of epi-pen.
Red dense rash near site if injection was noted this morning within 24 hours of vaccine.  I also received the RSV vaccine at the same time in the same arm.
Something of a cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Something of a cough) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Something of a cough). At the time of the report, COUGH (Something of a cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment medications reported.   She reported that she was one of the first ones to get the 1st dose after the front liners. It was reported that patient read at  Moderna website that if one has an upper respiratory infection it could be COVID rather than something else.
swelling of left supraclavicular node (2 hrs and continuing), dizziness/syncope (upon standing or palpitation of left supraclavicular node), fatigue, nausea (upon palpitation of left supraclavicular node)
Information has been received from a registered nurse (RN) referring to a patient of unknown gender and unknown age. The information of concurrent conditions, medical history and concomitant medications was not provided. On 22-SEP-2015, the patient received an expired dose of PNEUMOVAX 23 single dose vial (lot # J009723, expiration date 30-JAN-2015) 0.5 ml, intramuscularly (Expired product administered). No adverse effects were reported. Additional information has been requested.
Patient felt some dizziness 15min post vaccination, itchiness behind both ears, some nausea, tingling feeling all over body. Pt denies worsening of symptoms 10 minutes later, reports itchiness behind ears feeling slightly better. Does report an area on abdomen feeling itchy as well as random spots on both legs. Pt agreed to 50mg of Diphenhydramine, tabs, PO 20 minutes after first sx developed. Lot# 205355, exp. 05/2023, NDC 0904-5306-61. Patient was monitored for an extra 15 minutes post medication, was feeling better and had her husband outside waiting for her to drive her home. Advised to continue to monitor sx and call PCP with new sx or for emergent sx, go to ED. Patient denied trouble breathing, chest pain/tightening, trouble swallowing throughout whole event.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 03-JUL-2013, the patient was vaccinated with a dose of VARIVAX (Merck) (lot # J001179, expiration date 31-JAN-2015). The vaccine was stored improperly at temperatures up to 21F from 01-JUL-2013 to 08-OCT-2013, On 08-OCT-2013, vaccines were discarded, No adverse effects were reported. It was unspecified if the patient had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
I started feeling a little tickle in my lungs. Several days went by and I was not feeling good. We went out of town, and I forgot my inhaler, so, I went to urgent care to get a prescription for albuterol, and they told me that I needed prednisone too.
This spontaneous report was received from a Registered nurse regarding 17 years old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 19-JUN-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis (product storage error). No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports from the same reporter. Sender's Comments: US-009507513-1804USA005153.
Pt ran a fever of 102 degrees F and had the chills. Symptoms started about 8 hours after administration and lasted about 4 hours.
joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (joint pain). At the time of the report, ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.
I was not able to sleep. I felt like I had the flu. I was dizzy and tired. I had headache. I had brain fog and really dizzy. My doctor a brain scan. It show that I had a hematoma in my brain.
Itching, swelling to neck, wheals starting within 5 minutes. Benadryl IM given.
on 2MAY93 or 3MAY93 commented of not feeling well; went to ER on 6MAY93 w/cough & sore throat; given Bi-cillin & cough rxn w/Codeine; called in sick to work w/virus on 7MAY93; dec 8MAY93;
Roughly 8 hours after taking the vaccine I started feeling really weak, I fell asleep without realizing it woke up with body aches and pains, nausea and diarrhea, extreme headache and getting cold chills, I have been sleeping and on and off and weaker than normal and achy for 2 days now!
Got very dizzy and cold sweats a few minutes after vaccine. Then I had a seizure and thankfully my husband was there and called the paramedics because he thought I was having a stroke and when they came I was waking up but I had very blurry vision and I was very very sleepy and my memory wasn't very good. The paramedics came and checked my vitals and my blood pressure was very very low but I got to feeling better and stayed there for more time. I was very very tired and my memory was kind of bad for the rest of the day. My husband said I was twitching and my eyes were rolled back when I was seizing and he was a little over a minute when I was seizing.
tiredness; muscle pain/painful muscles; chills; joint pain/joint pain particularly at wrist and elbow; arm pain; beginnings of rash on palm and arm(right side)/rash develops on arm; shooting pains in right arm; hot to touch; joints somewhat swollen; rash continues to develop into blisters on palm; painful to touch, can't really use it much due to pain; painful to touch, can't really use it much due to pain; This is a spontaneous report from a contactable consumer, the patient. A 52-years-old non-pregnant female patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration, administered in Arm Right on 29Apr2021 at 13:00 as dose 1, single (at the age of 52-years-old) for covid-19 immunization at Hospital. The patient was non-pregnant at the time of vaccination. Medical history included poliomyelitis (possible nascent arthritis (undiagnosed), polio as a child) and seasonal allergy (not known at the time; only seasonal allergies). Concomitant medication included loratadine for an unspecified indication from an unspecified date and unknown if was ongoing. The patient did not have or diagnose covid prior to the vaccination. The patient had not been tested for covid post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After 1 and 2 days after the vaccination on 02May2021, the patient experienced the tiredness, muscle pain, chills, joint pain, arm pain, beginnings of rash on palm and arm (right side), Days 3 to 5 patient had shooting pains in right arm, hot to touch, joint pain particularly at wrist and elbow, joints somewhat swollen, rash continued to develop into blisters on palm and rash developed on arm (little spots groups in diffused circular pattern). On day 6-10, the extreme painful blisters on palm (4 major ones), painful to touch, could not really use it much due to pain, rash on arm developed into two major blister spots (one at elbow, the other upper arm. Still painful muscles and shooting pains down arm. Smaller individual blisters form on fingers. On days 11 to 13, blisters started to subside although still had joint pain at wrist and elbow. On days 13 to 16, blisters definitely subsiding on arm, dried up, took longer on palm. The patient still had joint pain throughout all, the patient had been taking double dose of ibuprofen for the pain, and generic claritin for the inflammation (within 2 weeks of vaccination). The case reported as non-serious. Device Date was reported as, 16May2021. The outcome of the events was resolving.The lot number for the vaccine, [BNT162B2], was not provided and would be requested during follow up.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20.2A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use on 26-Apr-2020.    On 23-Dec-2020 at 1:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 26-Apr-2020 and the estimated date of delivery was 31-Jan-2021. On 23-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fourth week of the pregnancy.  The patient was treated with MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) ongoing since an unknown date at an unspecified dose and frequency. On 23-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-May-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) to be not applicable.; Reporter's Comments: This case concerns a 32 year-old, female patient, who is 34 weeks pregnant who experienced an event of exposure during pregnancy after receiving her first dose of COVID-19 vaccine. No adverse events were reported.